Eisai to Present The Latest Lecanemab Data, Including Aria-E And Subcutaneous Formulation, And Other Alzheimer's Disease Research at The Alzheimer's Association International Conference (AAIC) 2022TOKYO
/PRNewswire/ Eisai Co. Ltd (Headquarters: Toyoko, CEO: Haruo Naito, "Eisai") announced today that the company will present research from its Alzheimer s.
acnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acnnewswire.com Daily Mail and Mail on Sunday newspapers.